Publication:
Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates.

dc.contributor.authorBorrego-Jimenez, J
dc.contributor.authorSoria-Segarra, C
dc.contributor.authorMoldovan, T D
dc.contributor.authorNavarro-Mari, J M
dc.contributor.authorGutierrez-Fernandez, J
dc.date.accessioned2023-02-08T14:39:02Z
dc.date.available2023-02-08T14:39:02Z
dc.date.issued2019-11-03
dc.description.abstractThe increasing prevalence of multidrug-resistant non-fermenting Gram-negative bacilli has led to a resurgence in the use of colistin for treating infections caused by these microorganisms. However, assessing colistin susceptibility remains challenging in microbiology laboratories. Common methods, such as disc diffusion and E-test, have been deemed unreliable due to high rates of false resistance. According to EUCAST guidelines, the gold standard for colistin susceptibility testing is broth microdilution, despite its labor-intensive manual process. Automated alternatives, such as Sensititre (ThermoFisher Diagnostics) and MicroScan (Beckman Coulter), have shown false resistance rates of up to 65%. A promising method aligned with EUCAST recommendations is the manual microdilution used in the UMic test (BioCentric), which our laboratory employs to confirm resistance results obtained from the MicroScan system. This study aims to compare the performance of automated MicroScan and E-test (gradient diffusion) methods against the manual UMic microdilution method.
dc.description.versionYes
dc.identifier.citationBorrego-Jiménez J, Soria-Segarra C, Moldovan TD, Navarro-Marí JM, Gutiérrez-Fernández J. Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates. Rev Esp Quimioter. 2020 Feb;33(1):83-84
dc.identifier.doi10.37201/req/076.2019
dc.identifier.essn1988-9518
dc.identifier.issn0214-3429
dc.identifier.issn0214-3429
dc.identifier.pmcPMC6987618
dc.identifier.pmid31895527
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987618/pdf
dc.identifier.unpaywallURLhttps://seq.es/wp-content/uploads/2020/01/borrego02jan2020.pdf
dc.identifier.urihttp://hdl.handle.net/10668/14909
dc.issue.number1
dc.journal.titleRevista espanola de quimioterapia
dc.journal.titleabbreviationRev Esp Quimioter
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number83-84
dc.provenanceCuración de contenido realizada 19/11/2024
dc.publisherSociedad Española de quimioterapia
dc.pubmedtypeComparative Study
dc.pubmedtypeLetter
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectAcinetobacter baumannii
dc.subjectPseudomonas aeruginosa
dc.subjectcolistin
dc.subject.decsAcinetobacter baumannii
dc.subject.decsColistina
dc.subject.decsPruebas antimicrobianas de difusión por disco
dc.subject.decsPruebas de sensibilidad microbiana
dc.subject.decsPseudomonas aeruginosa
dc.subject.meshAcinetobacter baumannii
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshColistin
dc.subject.meshDisk Diffusion Antimicrobial Tests
dc.subject.meshFalse Positive Reactions
dc.subject.meshHumans
dc.subject.meshMicrobial Sensitivity Tests
dc.subject.meshPseudomonas aeruginosa
dc.titleUse of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number33
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6987618.pdf
Size:
91.53 KB
Format:
Adobe Portable Document Format